Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders
The past two decades have seen a tremendous growth in knowledge related to cannabinoid receptor signaling in brain. In addition, the impact and consequences of cannabinoid modulation of monoaminergic circuits is steadily emerging demonstrating a significant interaction between these two systems in...
| Συγγραφή απο Οργανισμό/Αρχή: | |
|---|---|
| Άλλοι συγγραφείς: | |
| Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
| Γλώσσα: | English |
| Έκδοση: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Θέματα: | |
| Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Endocannabinoids and monoamines: modulating the modulators
- Endocannabinoid-mediated synaptic plasticity
- Current cannabinoid receptor nomenclature and pharmacological principles
- Cue-elicited craving for cannabis activates the reward neurocircuitry associated with the neuropathology of addiction
- Cannabinoid modulation of dopaminergic circuits in neurodegenerative and neuropsychiatric disorders
- Pathophysiology of mood disorders and mechanisms of action of antidepressants and mood stabilizers
- Anatomical, biochemical and behavioral evidence for cannabinoid modulation of noradrenergic circuits: role of norepinephrine in cannabinoid-induced aversion
- Gender Disparity of Depression: The Role of Endocannabinoids and Noradrenergic Function
- Endocannabinoids, Monoamines and Stress
- Chronic effects of cannabinoid drugs on monoaminergic systems and the role of endocannabinoids and cannabinoid receptors in human brain disorders
- Endocannabinoid Signaling and the Regulation of the Serotonin System
- Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors
- Involvement of serotonergic system in cannabinoid analgesia
- Cannabinoids, monoamines, COMT and schizophrenia: pathobiological mechanisms in psychosis.
